# \[e-drug\] Business behaviour of Boehringer Ingelheim, Bayer and Baxter in Brazil

**URL:** <https://talk.edrugplus.org/t/e-drug-business-behaviour-of-boehringer-ingelheim-bayer-and-baxter-in-brazil/38962>\
**Category:** e-drug\
**Created:** [May 17, 2013, 3:24pm UTC](https://talk.edrugplus.org/t/e-drug-business-behaviour-of-boehringer-ingelheim-bayer-and-baxter-in-brazil/38962 "2013-05-17T15:24:17Z")\
**Posts on this page:** 1\
**Page:** 1

<div class="post-metadata">

**Author:** ![Hedwig\_Diekwisch](https://avatars.discourse-cdn.com/v4/letter/h/54ee81/32.png) [@Hedwig\_Diekwisch](https://talk.edrugplus.org/u/Hedwig_Diekwisch)\
**Post date:** [May 17, 2013, 3:24pm UTC](https://talk.edrugplus.org/t/e-drug-business-behaviour-of-boehringer-ingelheim-bayer-and-baxter-in-brazil/38962/1 "2013-05-17T15:24:17Z")

</div>

E-DRUG: Business behaviour of Boehringer Ingelheim, Bayer and Baxter in Brazil  
----------------------------------------------------------------------------------

BUKO Pharma-Kampagne publishes new study

Dear e-druggers,

Please find below the link to our latest study: "At the expense of the  
poor? - Examination on the business behaviour of Bayer, Baxter and  
Boehringer Ingelheim in Brazil". The publication presents detailed  
information on the companies´ portfolios in Brazil, access and prices of  
their drugs in public and private health facilities, the companies´  
marketing behaviour, patent policy and clinical studies.

The data collection in Brazil (2011-2012) was carried out by Rogério  
Hoefler, a pharmacist from Centro Brasileiro de Informação sobre  
Medicamentos (Cebrim) / Conselho Federal de Farmácia (CFF). The brochure  
contains an annex which lists every examined drug with its price and  
classification.

[http://www.bukopharma.de/uploads/file/Pharma-Brief/E2012\_03\_special\_Braz](http://www.bukopharma.de/uploads/file/Pharma-Brief/E2012_03_special_Braz)  
il\_final.pdf [PDF/2mB]  
[Please fix URL in browser if broken]

In 2011 BUKO Pharma-Kampagne already published a study on the business  
behaviour of Bayer, Baxter and Boehringer Ingelheim in India, using the  
same methodology. Learn more:  
[http://www.en.bukopharma.de/index.php?page=Publications](http://www.en.bukopharma.de/index.php?page=Publications)  
[Please fix URL in browser if broken]

Please follow us on Twitter www.twitter.com/BUKOPharma  
or on Facebook  
[https://www.facebook.com/pages/BUKO-Pharma-Kampagne/195866943847728](https://www.facebook.com/pages/BUKO-Pharma-Kampagne/195866943847728)

Hedwig Diekwisch  
BUKO Pharma-Kampagne / Gesundheit und Dritte Welt e.V.  
August-Bebel-Str. 62  
33602 Bielefeld  
Tel.: +49 (0)521 60550  
Fax.: +49 (0)521 63789
